搜尋
Aquestive Therapeutics Inc
AQST添加自選
3.695USD
-0.025-0.67%
收盤 07-31 16:00（美東）報價延遲15分鐘
463.60M總市值
虧損本益比TTM
關於 Aquestive Therapeutics Inc 公司
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.
Aquestive Therapeutics Inc簡介
公司代碼AQST
公司名稱Aquestive Therapeutics Inc
上市日期Jul 25, 2018
CEOBarber (Daniel R)
員工數量142
證券類型Ordinary Share
年結日Jul 25
公司地址30 Technology Dr
城市WARREN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07059-5166
電話19089411900
網址https://aquestive.com/
公司代碼AQST
上市日期Jul 25, 2018
CEOBarber (Daniel R)
Aquestive Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Mrs. Abigail L. Jenkins
Mrs. Abigail L. Jenkins
Independent Director
Independent Director
19.00K
--
Dr. Melina T. Cioffi, Pharm.D.
Dr. Melina T. Cioffi, Pharm.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. John S. Cochran, CPA
Mr. John S. Cochran, CPA
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
常見問題
Aquestive Therapeutics Inc的前五大股東是誰？
Aquestive Therapeutics Inc的前五大股東如下：Mr. Daniel Barber
有多少機構持有Aquestive Therapeutics Inc(AQST)的股份？
截至2026Q1，共有350家機構持有Aquestive Therapeutics Inc的股份，合計持有的股份價值約為74.94M，占公司總股份的60.30% 。與2025Q4相比，機構持股有所增加，增幅為-7481130.00。